Low-density lipoprotein receptor-related protein 1 is associated with proliferation and invasiveness in Her-2/neu and triple-negative breast carcinomas

Human Pathology

Volumn 42, Issue 11, 2011, Pages 1581-1588

  Catasus, Lluis ^a   Gallardo, Alberto ^a   Llorente Cortes, Vicenta ^a   Escuin, Daniel ^a   Muñoz, Josefina ^a   Tibau, Ariadna ^a   Peiro, Gloria ^b   Barnadas, Agusti ^a   Lerma, Enrique ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b Research Unit   (Spain)

Author keywords

Breast carcinoma; Cholesterol levels; Her 2 neu; Low density lipoprotein receptor related protein 1; Triple negative

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN;

ADULT; AGED; ARTICLE; BREAST CARCINOMA; CANCER ADJUVANT THERAPY; CANCER GRADING; CANCER INVASION; CANCER RADIOTHERAPY; CANCER SIZE; CANCER SURVIVAL; CELL PROLIFERATION; GENE OVEREXPRESSION; HUMAN; IMMUNOHISTOCHEMISTRY; INTRADUCTAL CARCINOMA; MAJOR CLINICAL STUDY; MITOSIS INDEX; PROGNOSIS; TISSUE MICROARRAY;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CHOLESTEROL; FEMALE; HUMANS; HYPERCHOLESTEROLEMIA; LOW DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN-1; MIDDLE AGED; NEOPLASM INVASIVENESS; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 80053310793     PISSN: 00468177     EISSN: 15328392     Source Type: Journal    
DOI: 10.1016/j.humpath.2011.01.011     Document Type: Article

References (44)

1. A. Jemal, R. Siegel, E. Ward, Y. Hao, J. Xu, and M.J. Thun Cancer statistics, 2009 CA Cancer J Clin 59 2009 225 249
2. I.O. Ellis, S.J. Schnitt, and X. Sastre-Garau Invasive breast carcinoma F.A. Tavassoli, P. Devilee, Tumors of the breast and female genital organs 2003 IARC press Lyon 13 59
3. C.W. Elston, and I.O. Ellis Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up Histopathology 19 1991 403 410
4. C. Sotiriou, and L. Pusztai Gene-expression signatures in breast cancer N Engl J Med 360 2009 790 800
5. T. Sørlie, C.M. Perou, and R. Tibshirani Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications Proc Natl Acad Sci USA 98 2001 10869 10874 (Pubitemid 32878711)
6. L.J. van 't Veer, H. Dai, and M.J. van de Vijver Gene expression profiling predicts clinical outcome of breast cancer Nature 415 2002 530 536 (Pubitemid 34130608)
7. C. Sotiriou, S.Y. Neo, and L.M. McShane Breast cancer classification and prognosis based on gene expression profiles from a population based study Proc Natl Acad Sci USA 100 2003 10393 10398 (Pubitemid 37071889)
8. E. Huang, S.H. Cheng, and H. Dressman Gene expression predictors of breast cancer outcomes Lancet 361 2003 1590 1596 (Pubitemid 36578995)
9. G. Callagy, E. Cattaneo, and Y. Diago Molecular classification of breast carcinomas using tissue microarrays Diag Mol Pathol 12 2003 27 34 (Pubitemid 36255267)
10. K.R. Bauer, M. Brown, R.D. Cress, C.A. Parise, and V. Caggiano Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype. Population-based study from the California Cancer Registry Cancer 109 2007 1721 1728 (Pubitemid 46668532)
11. P.L. Nguyen, A.G. Taghian, and M.S. Katz Breast cancer subtype approximated by estrogen receptor, progesterone receptor, and HER-2 is associated with local and distant recurrence after breast-conserving therapy J Clin Oncol 26 2008 2373 2378
12. M. Smid, Y. Wang, and Y. Zhang Subtypes of breast cancer show preferential site of relapse Cancer Res 68 2008 3108 3114
13. A.P. Lillis, L.B. Van Duyn, J.E. Murphy-Ullrich, and D.K. Strickland LDL receptor-related protein 1: unique tissue-specific functions revealed by selective gene knockout studies Physiol Rev 88 2008 887 918
14. J. Herz, and D.K. Strickland LRP1: a multifunctional scavenger and signaling receptor J Clin Invest 108 2001 779 784 (Pubitemid 32880284)
15. C. Lutz, J. Nimpf, and M. Jenny Evidence of functional modulation of the MEKK/JNK/cJun signaling cascade by the LRP J Biol Chem 277 2002 43143 43151
16. P. van der Geer Phosphorylation of LRP1: regulation of transport and signal transduction Trends Cardiovasc Med 12 2002 160 165 (Pubitemid 34586819)
17. H. Song, Y. Li, J. Lee, A.L. Schwartz, and G. Bu Low-density lipoprotein receptor-related protein 1 promotes cancer cell migration and invasion by inducing the expression of matrix metalloproteinases 2 and 9 Cancer Res 69 2009 879 886
18. B. Fayard, F. Bianchi, and J. Dey The serine protease inhibitor protease nexin-1 controls mammary cancer metastasis through LRP-1-mediated MMP-9 expression Cancer Res 69 2009 5690 5698
19. Y. Li, N. Wood, P. Grimsley, D. Yellowlees, and P.K. Donnelly In vitro invasiveness of human breast cancer cells is promoted by low density lipoprotein receptor-related protein Invasion Metastasis 18 1998-1999 240 251 (Pubitemid 30223700)
20. V. Montel, A. Gaultier, R.D. Lester, W.M. Campana, and S.L. Gonias The low-density lipoprotein receptor-related protein regulates cancer cell survival and metastasis development Cancer Res 67 2007 9817 9824 (Pubitemid 47621229)
21. B. Chazaud, R. Ricoux, C. Christov, A. Plonquet, R.K. Gherardi, and G. Barlovatz-Meimon Promigratory effect of plasminogen activator inhibitor-1 on invasive breast cancer cell populations Am J Pathol 160 2002 237 246 (Pubitemid 34052284)
22. R.K. Kancha, M.E. Stearns, and M.M. Hussain Decreased expression of LRP1 in invasive cell clones derived from human prostate and breast tumor cells Oncol Res 6 1994 365 372
23. T.J. de Vries, J.H. Verheijen, A.C. de Bart, U.H. Weidle, D.J. Ruiter, and G.N. van Muijen Decreased expression of both the LRP1 and its receptor-associated protein in late stages of cutaneous melanocytic tumor progression Cancer Res 56 1996 1432 1439
24. R.R. Desrosiers, M.E. Rivard, P.E. Grundy, and B. Annabi Decrease in LDL receptor-related protein expression and function correlates with advanced stages of Wilms tumors Pediatr Blood Cancer 46 2006 40 49 (Pubitemid 41779316)
25. K. Obermeyer, S. Krueger, B. Peters, B. Falkenberg, A. Roessner, and C. Röcken The expression of LRP1 protein in colorectal carcinoma Oncol Rep 17 2007 361 367
26. V. Llorente-Cortés, M. Otero-Viñas, S. Sánchez, C. Rodríguez, and L. Badimon Low-density lipoprotein upregulates low-density lipoprotein receptor-related protein expression in vascular smooth muscle cells: possible involvement of sterol regulatory element binding protein-2-dependent mechanism Circulation 106 2002 3104 3110 (Pubitemid 35440296)
27. V. Llorente-Cortés, J. Martínez-González, and L. Badimon LDL receptor-related protein mediates uptake of aggregated LDL in human vascular smooth muscle cells Arterioscler Thromb Vasc Biol 20 2000 1572 1579 (Pubitemid 30353890)
28. S.M. Hofmann, L. Zhou, and D. Perez-Tilve Adipocyte LDL receptor-related protein-1 expression modulates postprandial lipid transport and glucose homeostasis in mice J Clin Invest 117 2007 3271 3282 (Pubitemid 350096984)
29. S. Dedieu, and B. Langlois LRP-1: a new modulator of cytoskeleton dynamics and adhesive complex turnover in cancer cells Cell Adh Migr 2 2008 77 80
30. B. Langlois, H. Emonard, L. Martiny, and S. Dedieu Multiple involvements of LRP-1 receptor in tumor progression Pathol Biol (Paris) 57 2009 548 554
31. B. Langlois, G. Perrot, and C. Schneider LRP-1 promotes cancer cell invasion by supporting ERK and inhibiting JNK signaling pathways PLoS One e11584 2010 5
32. Y. Li, N. Wood, P. Donnelly, and D. Yellowlees Cell density and oestrogen both stimulate alpha 2-macroglobulin receptor expression in breast cancer cell T-47D Anticancer Res 18 1998 1197 1202 (Pubitemid 28239663)
33. L. Christensen, A.C.W. Simonsen, C.W. Heegaard, S.K. Moestrup, J.A. Andersen, and P.A. Andreasen Immunohistochemical localization of urokinase-type plasminogen activator, type-1 plasminogen-activator inhibitor, urokinase receptor and beta-2-macroglobulin receptor in human breast carcinomas Int J Cancer 66 1996 441 452
34. S.K. Moestrup, J. Gliemann, and G. Pallesen Distribution of the LRP1 in human tissues Cell Tissue Res 269 1992 375 382
35. D.W. Russell, W.J. Schneider, T. Yamamoto, K.L. Luskey, M.S. Brown, and J.L. Goldstein Domain map of the LDL receptor: sequence homology with the epidermal growth factor precursor Cell 37 1984 577 585 (Pubitemid 14079052)
36. E. Lerma, A. Barnadas, and J. Prat Triple negative breast carcinomas: similarities and differences with basal like carcinomas Appl Immunohistochem Mol Morphol 17 2009 483 494
37. H.S. Earp, T.L. Dawson, X. Li, and H. Yu Heterodimerization and functional interaction between EGF receptor family members: a new signaling paradigm with implications for breast cancer research Breast Cancer Res Treat 35 1995 115 132
38. E. de Azambuja, F. Cardoso, and G. de Castro Jr Ki-67 as prognostic marker in early breast cancer: a meta-analysis of published studies involving 12,155 patients Br J Cancer 96 2007 1504 1513 (Pubitemid 46762956)
39. V. Llorente-Cortés, P. Costales, J. Bernués, S. Camino-Lopez, and L. Badimon Sterol regulatory element-binding protein-2 negatively regulates low density lipoprotein receptor-related protein transcription J Mol Biol 359 2006 950 960 (Pubitemid 43831923)
40. A.S. Furberg, M.B. Veierød, T. Wilsgaard, L. Bernstein, and I. Thune Serum high-density lipoprotein cholesterol, metabolic profile, and breast cancer risk J Natl Cancer Inst 96 2004 1152 1160 (Pubitemid 39207051)
41. B. Maiti, M.N. Kundranda, T.P. Spiro, and H.A. Daw The association of metabolic syndrome with triple-negative breast cancer Breast Cancer Res Treat 121 2010 479 483
42. M.J. Campbell, L.J. Esserman, and Y. Zhou Breast cancer growth prevention by statins Cancer Res 66 2006 8707 8714 (Pubitemid 44449187)
43. K. Gauthaman, C.Y. Fong, and A. Bongso Statins, stem cells, and cancer J Cell Biochem 106 2009 975 983
44. J. Haukka, R. Sankila, and T. Klaukka Incidence of cancer and statin usage-record linkage study Int J Cancer 126 2010 279 284